Kantonsspital St.Gallen

Expression of the extra domain B of fibronectin, a marker of angiogenesis, in head and neck tumors

Manfred T Birchler, Dusan Milisavlijevic, Madeleine Pfaltz, Dario Neri, Bernhard Odermatt, Stefan Schmid & Sandro Stöckli

abstract OBJECTIVES/HYPOTHESIS: The extra domain B (ED-B) of fibronectin, a naturally occurring marker of tissue remodeling and angiogenesis, is expressed in the majority of aggressive solid human tumors, whereas it is not detectable in normal vessels and tissues. STUDY DESIGN: In view of the diagnostic and therapeutic clinical applications of the L19 antibody, which is specific for the ED-B domain of fibronectin, a prospective immunohistochemical analysis of different head and neck tumors was performed. METHODS: In all, 82 head and neck tissue biopsy specimens were immunohistochemically analyzed using the L19 antibody. They consisted of 53 different malignant tumors, 8 benign tumors, 10 nontumoral lesions, and 11 normal control tissues. RESULTS: A strong positive staining with the L19 antibody could be observed in 87% of the investigated malignant tumors, in only 38% of the benign tumors, and in 20% of the nontumoral lesions (P <.0001). The extra domain B was completely absent in the normal control tissue samples. CONCLUSIONS: The results show that ED-B is abundantly expressed around the neovasculature and in the stroma of the majority of malignant tumors of the head and neck but is undetectable in normal tissues. The ED-B domain of fibronectin is a good-quality tumor-stroma-associated antigen that warrants clinical trials with antibody-based pharmaceuticals, including immunoscintigraphic investigations and radioimmunoguided surgery with the radiolabeled L19 antibody.
citation Birchler M T, Milisavlijevic D, Pfaltz M, Neri D, Odermatt B, Schmid S, Stöckli S. Expression of the extra domain B of fibronectin, a marker of angiogenesis, in head and neck tumors. The Laryngoscope 2003; 113:1231-7.
type journal paper/review (English)
date of publishing 7-2003
journal title The Laryngoscope (113/7)
ISSN print 0023-852X
pages 1231-7
PubMed 12838025
DOI 10.1097/00005537-200307000-00023